Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:CNBSNASDAQ:FMEDNASDAQ:HRTSNYSEARCA:KGRN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCNBSAmplify Seymour Cannabis ETF$14.30-3.7%$16.52$14.21▼$60.00$52.05M1.2921,168 shs7,394 shsFMEDFidelity Disruptive Medicine ETF$23.28-0.3%$23.42$20.69▼$26.79$48.89M1.035,761 shs2,878 shsHRTSTema GLP-1, Obesity & Cardiometabolic ETF$27.98-1.0%$27.97$25.32▼$36.03$53.16M0.939,815 shs3,247 shsKGRNKraneShares MSCI China Clean Technology Index ETF$25.30-1.6%$25.66$18.74▼$28.00$51.87M0.6213,922 shs13,108 shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCNBSAmplify Seymour Cannabis ETF-3.70%-1.45%-14.78%-17.67%-97.77%FMEDFidelity Disruptive Medicine ETF-0.32%-1.79%+0.39%-5.02%-0.64%HRTSTema GLP-1, Obesity & Cardiometabolic ETF-1.03%-2.88%+1.89%-6.67%-13.21%KGRNKraneShares MSCI China Clean Technology Index ETF-1.56%-1.98%-7.29%-3.32%+24.32%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCNBSAmplify Seymour Cannabis ETFN/AN/AN/AN/AN/AN/AN/AN/AFMEDFidelity Disruptive Medicine ETFN/AN/AN/AN/AN/AN/AN/AN/AHRTSTema GLP-1, Obesity & Cardiometabolic ETFN/AN/AN/AN/AN/AN/AN/AN/AKGRNKraneShares MSCI China Clean Technology Index ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCNBSAmplify Seymour Cannabis ETF 2.49Hold$14.30N/AFMEDFidelity Disruptive Medicine ETF 2.84Moderate Buy$23.28N/AHRTSTema GLP-1, Obesity & Cardiometabolic ETF 2.76Moderate Buy$27.98N/AKGRNKraneShares MSCI China Clean Technology Index ETF 1.57Reduce$25.30N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCNBSAmplify Seymour Cannabis ETFN/AN/AN/AN/AN/AN/AFMEDFidelity Disruptive Medicine ETFN/AN/AN/AN/AN/AN/AHRTSTema GLP-1, Obesity & Cardiometabolic ETFN/AN/AN/AN/AN/AN/AKGRNKraneShares MSCI China Clean Technology Index ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCNBSAmplify Seymour Cannabis ETFN/AN/A17.73∞N/AN/AN/AN/AN/AFMEDFidelity Disruptive Medicine ETFN/AN/A37.99∞N/AN/AN/AN/AN/AHRTSTema GLP-1, Obesity & Cardiometabolic ETFN/AN/A24.84∞N/AN/AN/AN/AN/AKGRNKraneShares MSCI China Clean Technology Index ETFN/AN/A16.46∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCNBSAmplify Seymour Cannabis ETF$10.7274.97%N/AN/AN/AFMEDFidelity Disruptive Medicine ETF$0.110.47%N/AN/AN/AHRTSTema GLP-1, Obesity & Cardiometabolic ETF$0.461.64%N/AN/AN/AKGRNKraneShares MSCI China Clean Technology Index ETF$0.331.30%N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCNBSAmplify Seymour Cannabis ETFN/AFMEDFidelity Disruptive Medicine ETFN/AHRTSTema GLP-1, Obesity & Cardiometabolic ETFN/AKGRNKraneShares MSCI China Clean Technology Index ETFN/AInsider OwnershipCompanyInsider OwnershipCNBSAmplify Seymour Cannabis ETFN/AFMEDFidelity Disruptive Medicine ETFN/AHRTSTema GLP-1, Obesity & Cardiometabolic ETFN/AKGRNKraneShares MSCI China Clean Technology Index ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCNBSAmplify Seymour Cannabis ETFN/A3.64 millionN/ANot OptionableFMEDFidelity Disruptive Medicine ETFN/A2.10 millionN/ANot OptionableHRTSTema GLP-1, Obesity & Cardiometabolic ETFN/A1.90 millionN/AN/AKGRNKraneShares MSCI China Clean Technology Index ETFN/A2.05 millionN/ANot OptionableKGRN, HRTS, FMED, and CNBS HeadlinesRecent News About These CompaniesHow To Trade (KGRN)January 27, 2025 | news.stocktradersdaily.comChina Market Update: Fintech Lender Shows Improving Consumer, China Gears Up For Trade NegotiationNovember 21, 2024 | forbes.comHow to Take Advantage of moves in (KGRN)November 3, 2024 | news.stocktradersdaily.comWhen (KGRN) Moves Investors should ListenOctober 23, 2024 | news.stocktradersdaily.comKCAI KraneShares China Alpha Index ETFOctober 14, 2024 | seekingalpha.comWhen the Price of (KGRN) Talks, People ListenOctober 12, 2024 | news.stocktradersdaily.comEU must find right balance on clean tech trade with China, says DraghiSeptember 17, 2024 | reuters.comKraneShares China Alpha Index ETF (KCAI)September 17, 2024 | investing.com(KGRN) Technical Pivots with Risk ControlsSeptember 5, 2024 | news.stocktradersdaily.comChina's Industrial Overcapacity Puts It In 'Doom Loop,' Western Markets Are At Risk: AnalysisAugust 7, 2024 | benzinga.comLong Term Trading Analysis for (KGRN)July 24, 2024 | news.stocktradersdaily.comSolar Selloff: Dump These 3 Chinese Stocks Before Biden Tariffs Scorch ProfitsJune 14, 2024 | investorplace.comWhy NIO Shares Are Gaining Tuesday?May 21, 2024 | msn.comRace to Onshore Clean-Tech Supply Chains: BNEFMay 1, 2024 | bloomberg.comChina's overproduction of clean energy goods needs to be mitigated, Yellen saysApril 16, 2024 | msn.comInvest in the Ocean With KSEAMarch 25, 2024 | etftrends.com3 Thematic China ETFs for An Uncertain OutlookFebruary 26, 2024 | etftrends.comClean Tech Is Massive Contributor to China EconomyFebruary 16, 2024 | etftrends.comKraneshares Icav - MSCI China Clean Technology Ucits ETFJanuary 5, 2024 | investing.comChina Clean Tech Investments Paying OffDecember 28, 2023 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeKGRN, HRTS, FMED, and CNBS Company DescriptionsAmplify Seymour Cannabis ETF NYSEARCA:CNBS$14.30 -0.55 (-3.70%) Closing price 06/20/2025 04:10 PM EasternExtended Trading$14.54 +0.24 (+1.69%) As of 06/20/2025 07:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Amplify Growth Opportunities ETF (CNBS) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed portfolio of global stocks related to cannabis and hemp. The fund also invests in derivatives with similar characteristics. CNBS was launched on Jul 23, 2019 and is managed by Amplify.Fidelity Disruptive Medicine ETF NASDAQ:FMED$23.28 -0.06 (-0.26%) Closing price 06/20/2025 03:58 PM EasternExtended Trading$23.28 -0.01 (-0.02%) As of 06/20/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.Tema GLP-1, Obesity & Cardiometabolic ETF NASDAQ:HRTS$27.98 -0.29 (-1.03%) As of 06/20/2025 03:54 PM EasternThe Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.KraneShares MSCI China Clean Technology Index ETF NYSEARCA:KGRN$25.30 -0.40 (-1.56%) As of 06/20/2025 04:10 PM EasternThe KraneShares MSCI China Clean Technology ETF (KGRN) is an exchange-traded fund that is based on the MSCI China IMI Environment 10-40 index. The fund tracks an index of Chinese companies that derive at least 50% of their revenue from products and services that benefit the environment. KGRN was launched on Oct 13, 2017 and is managed by KraneShares. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Smith & Wesson Stock Falls on Earnings Miss, Tariff Woes Marvell's New AI Chip Deals Capture Wall Street’s Attention Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
